Pharmaceutical Lifecycle Management

Our firm's lawyers have assisted our clients with pharmaceutical lifecycle management strategy at every stage during the patent term. This not only includes Patent Term Extension and Patent Term Adjustment, but also patenting inventions related to:

Salt screens
Salt switches
Polymorph screens
New dosage forms
Intermediates and Metabolites
Improved bioavailability
Controlled release
Improved stability
New indications
New modes of administration
Pharmacokinetic profiles
Pharmacodynamic profiles
New dosage regimens
Methods of manufacture
Methods of screening
Risk Evaluation and Mitigation Strategies
Companion Diagnostics

The patent attorneys, engineers, scientists, and patent agents at Torrey Pines Law Group have worked in a variety of pharmaceutical industries, both branded and generic, and have assisted with commercializing, researching, and developing pharmaceutical technologies including:

Small molecule pharmaceuticals
Biopharmaceuticals
Central and peripheral pain therapeutics
Pharmaceutical formulations

Drug combinations
Pharmaceutical delivery methods
Immuno-Oncology Indications
Antiviral drug screening

Enzyme mimetics
New Salts and Polymorphs
Cardiovascular Indications

Torrey Pines Law Group, PC serves technology innovators with protecting intellectual property, obtaining regulatory approvals and clearances, and making deals and closing technology transactions throughout the U.S., including in major technology hubs such as San Diego, San Francisco, Palo Alto, San Jose, Silicon Valley, Boston, Cambridge, Chicago, Minneapolis, Houston, Dallas, Atlanta, Denver, Seattle, Portland, Boulder, Orlando, the Research Triangle (Raleigh, Durham, and Chapel Hill), the Mid-Atlantic (New Jersey, New York, Philadelphia, Maryland, Virginia, and Washington, DC), Pittsburgh, Cleveland, Ann Arbor, and throughout Southern California in Los Angeles, Orange County, Irvine, Torrey Pines, Sorrento Valley, and La Jolla.

We have experience with international intellectual property, regulatory and transactional matters pending in Beijing, Shanghai, Shenzhen, and Guangzhou China; Tokyo, Japan; Berlin, Munich and Frankfurt Gemany; Tel Aviv Israel; Mumbai, Bengaluru, and New Delhi India; London and Edinburgh United Kingdom; Vancouver, Toronto, Calgary and Montreal Canada; Dublin, Ireland; Cape Town, South Africa; Mexico City and Tijuana Mexico; Brussels, Belgium; Copenhagen, Denmark; Paris, France; Madrid and Barcelona Spain; Moscow, Russia; Santiago, Chile; Montevideo, Uruguay; Buenos Aires, Argentina; Sao Paulo and Rio de Janeiro Brazil; Seoul, South Korea; Taipei, Taiwan; Hong Kong; Hanoi, Vietnam; Bangkok, Thailand; Kuala Lumpur, Malaysia; Milan, Italy; Singapore; Sydney, Melbourne, Perth and Adelaide Australia; Auckland, New Zealand; Oslo, Norway; Stockholm, Sweden; Helsinki, Finland; Kiev, Ukraine; Budapest, Hungary; Vienna, Austria; Prague, Czechia; Geneva and Lausanne Switzerland; Bahrain; Doha, Qatar; Abu Dhabi and Dubai UAE; and Jeddah, Saudi Arabia.

Pharmaceutical Patent Attorneys - Pharmaceutical Patent Preparation & Prosecution Lawyer - Pharmaceutical Intellectual Property Litigation Law Firm - San Francisco Biopharmaceutical IP - New Jersey Pharmaceutical Lawyers - Cambridge Pharmaceutical Counsel